Can we really do computer-aided drug design?

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Drug Discovery

Background:

• Current drug discovery relies heavily on synthesis and testing, often involving numerous compounds.
• Computational methods are increasingly applied but face limitations in predictive accuracy.
• A true 'design' paradigm in drug discovery remains challenging due to model predictivity.

Purpose of the Study:

• To define 'design' in the context of drug discovery.
• To evaluate the current role and limitations of computational methods in drug design.
• To explore future directions for enhancing computational drug discovery.

Main Methods:

• Conceptual analysis of 'design' versus computational application.
• Review of current computational model predictivity in drug discovery.
• Discussion of strategies for improving computational model accuracy and transferability.

Main Results:

• Computational models, while not yet enabling true design, significantly reduce the number of compounds to test.
• These methods help eliminate compounds with low success probability.
• Appropriate application supports multi-parameter optimization for compound selection.

Conclusions:

• Computational methods are valuable tools for focusing drug discovery efforts.
• Further advancements are needed to achieve a genuine computational design process.
• Future research should focus on improving model accuracy and transferability for better drug design.